Shaham Y, Funk D, Erb S, Brown T J, Walker C D, Stewart J
Biobehavioral Research Department, Addiction Research Foundation, Toronto, Ontario, Canada M5S 2S1.
J Neurosci. 1997 Apr 1;17(7):2605-14. doi: 10.1523/JNEUROSCI.17-07-02605.1997.
We showed previously that brief footshock stress and priming injections of heroin reinstate heroin-seeking after prolonged drug-free periods. Here, we examined whether the adrenal hormone, corticosterone, and brain corticotropin-releasing factor (CRF) were involved in such reinstatement. We tested the effects of adrenalectomy, chronic exposure to the corticosterone synthesis inhibitor metyrapone (100 mg/kg, s.c., twice daily), acute exposure to metyrapone, acute intracerebroventricular injections of CRF (0.3 and 1.0 microgram), and intracerebroventricular injections of the CRF antagonist alpha-helical CRF (3 and 10 micrograms). Rats were trained to self-administer heroin (100 micrograms/kg/infusion, i.v.) for 12-14 d. Extinction sessions were given for 4-8 d (saline substituted for heroin). Tests for reinstatement were given after priming injections of saline and of heroin (0.25 mg/kg, s.c.), and after intermittent footshock (15 or 30 min, 0.5 mA). Adrenalectomy (performed after training) did not affect reinstatement by heroin but appeared to potentiate the reinstatement by footshock. Chronic exposure to metyrapone (from the beginning of extinction) or an acute injection of metyrapone (3 hr before testing) did not alter the reinstatement of heroin-seeking induced by footshock or heroin. Acute exposure to metyrapone alone potently reinstated heroin-seeking. In addition, acute exposure to CRF reinstated heroin-seeking, and the CRF antagonist alpha-helical CRF attenuated stress-induced relapse. The effect of the CRF antagonist on reinstatement by heroin was less consistent. These results suggest that CRF, a major brain peptide involved in stress, contributes to relapse to heroin-seeking induced by stressors.
我们之前曾表明,短暂的足部电击应激和海洛因的预注射会在长时间无药期后恢复觅药行为。在此,我们研究了肾上腺激素皮质酮和脑促肾上腺皮质激素释放因子(CRF)是否参与了这种恢复过程。我们测试了肾上腺切除术、长期暴露于皮质酮合成抑制剂美替拉酮(100毫克/千克,皮下注射,每日两次)、急性暴露于美替拉酮、急性脑室内注射CRF(0.3和1.0微克)以及脑室内注射CRF拮抗剂α-螺旋CRF(3和10微克)的效果。大鼠被训练自行静脉注射海洛因(100微克/千克/输注)12 - 14天。进行4 - 8天的消退训练(用生理盐水替代海洛因)。在生理盐水和海洛因(0.25毫克/千克,皮下注射)预注射后,以及间歇性足部电击(15或30分钟,0.5毫安)后进行恢复测试。肾上腺切除术(在训练后进行)不影响海洛因诱导的恢复,但似乎增强了足部电击诱导的恢复。长期暴露于美替拉酮(从消退开始)或急性注射美替拉酮(测试前3小时)不会改变足部电击或海洛因诱导的觅药行为的恢复。单独急性暴露于美替拉酮会显著恢复觅药行为。此外,急性暴露于CRF会恢复觅药行为,而CRF拮抗剂α-螺旋CRF会减弱应激诱导的复发。CRF拮抗剂对海洛因诱导的恢复的影响不太一致。这些结果表明,CRF是一种参与应激的主要脑肽,它促成了应激源诱导的海洛因觅药行为的复发。